Stemness and angiogenic gene expression changes of serial-passage human amnion mesenchymal cells

Microvascular Research

Volumn 86, Issue 1, 2013, Pages 21-29

  Fatimah, Simat Siti ^a   Tan, Geok Chin ^a   Chua, Kienhui ^a   Fariha, Mohd Manzor Nur ^a,b   Tan, Ay Eeng ^a   Hayati, Abdul Rahman ^a,b  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

^b UNIVERSITI SAINS ISLAM MALAYSIA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ANGIOPOIETIN 1; BREAST CANCER RESISTANCE PROTEIN; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CD9 ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 4; FRIZZLED PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HERMES ANTIGEN; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; NESTIN; OCTAMER TRANSCRIPTION FACTOR 4; REX PROTEIN; SCATTER FACTOR; STEM CELL FACTOR RECEPTOR; THY 1 ANTIGEN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR;

ADIPOCYTE; AMNION CELL; ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL STRUCTURE; CLONOGENESIS; COLONY FORMING UNIT; CONTROLLED STUDY; CULTURE MEDIUM; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; MESENCHYME CELL; MESODERM; MOLECULAR CLONING; NERVE CELL; NEUROECTODERM; NUCLEOTIDE SEQUENCE; OSTEOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

ADIPOCYTES; ADULT; AMNION; ANGIOGENIC PROTEINS; ANTIGENS, DIFFERENTIATION; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CULTURE MEDIA; EPITHELIAL CELLS; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; IMMUNOPHENOTYPING; MESENCHYMAL STROMAL CELLS; MESODERM; NEOVASCULARIZATION, PHYSIOLOGIC; NEURAL PLATE; NEURONS; OSTEOCYTES; PREGNANCY; PRIMARY CELL CULTURE; YOUNG ADULT;

BOVINAE;

EID: 84873714138     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2012.12.004     Document Type: Article

References (46)

1. Albelda S.M., Muller W.A., Buck C.A., Newman P.J. Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule. J. Cell Biol. 1991, 114:1059-1068.
2. Alviano F., Fossati V., Marchionni C., Arpinati M., Bonsi L., Franchina M., Lanzoni G., Cantoni S., Cavallini C., Bianchi F., Tazzari P.L., Pasquinelli G., Foroni L., Ventura C., Grossi A., Bagnara G.P. Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev. Biol. 2007, 7:11.
3. Asahara T., Bauters C., Zheng L.P., Takeshita S., Bunting S., Ferrara N., Symes J.F., Isner J.M. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 1995, 92:II365-II371.
4. Bailo M., Soncini M., Vertua E., Signoroni P.B., Sanzone S., Lombardi G., Arienti D., Calamani F., Zatti D., Paul P., Albertini A., Zorzi F., Cavagnini A., Candotti F., Wengler G.S., Parolini O. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation 2004, 78:1439-1448.
5. Breier G., Risau W. The role of vascular endothelial growth factor in blood vessel formation. Trends Cell Biol. 1996, 6:454-456.
6. Civin C.I. Commitment to biomedical research: clearing unnecessary impediment to progress. Stem Cells 2002, 20:482-484.
7. D'Ippolito G., Howard G.A., Roos B.A., Schiller P.C. Sustained stromal stem cell self-renewal and osteoblastic differentiation during aging. Rejuvenation Res. 2006, 9:10-19.
8. Fariha M.M., Chua K.H., Tan G.C., Tan A.E., Hayati A.R. Human chorion-derived stem cells: changes in stem cell properties during serial passage. Cytotherapy 2011, 13:582-593.
9. Fatimah S.S., Ng S.L., Chua K.H., Hayati A.R., Tan A.E., Tan G.C. Value of human amniotic epithelial cells in tissue engineering for cornea. Hum. Cell 2010, 23:141-151.
10. Frank H.G., Morrish D.W., Pötgens A., Genbacev O., Kumpel B., Caniggia I. Cell culture models of human trophoblasts: primary culture of the trophoblast - a workshop report. Placenta 2001, 22:S107-S109.
11. Freed C.R. Will embryonic stem cells be a useful source of dopamine neurons for transplant into patients with parkinson's disease?. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:1755-1757.
12. Girma J.P., Meyer D., Verweij C.L., Pannekoek H., Sixma J.J. Structure-function relationship of human von Willebrand factor. Blood 1987, 70:605-611.
13. Hayati A.R., NurFariha M.M., Tan G.C., Tan A.E., Chua K. Potential of human deciduas stem cells for angiogenesis and neurogenesis. Arch. Med. Res. 2011, 42:291-300.
14. Jain R.K., Au P., Tam J., Duda D.G., Fukumura D. Engineering vascularized tissue. Nat. Biotechnol. 2005, 23:821-823.
15. Keyt B.A., Nguyen H.V., Berleau L.T., Duarte C.M., Park J., Chen H., Ferrara N. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J. Biol. Chem. 1996, 271:5638-5646.
16. Kubo M., Sonoda Y., Muramatsu R., Usui M. Immunogenicity of human amniotic membrane in experimental xenotransplantation. Invest. Ophthalmol. Vis. Sci. 2001, 42:1539-1546.
17. Mareschi K., Ferrero I., Rustichelli D., Aschero S., Gammaitoni L., Aglietta M., Madon E., Fagioli F. Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow. J. Cell. Biochem. 2006, 97:744-754.
18. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 1991, 43:109-142.
19. Muraoka O., Tanaka H., Itoh M., Ishihara K., Hirano T. Genomic structure of human BST-1. Immunol. Lett. 1996, 54:1-4.
20. Niwa H., Miyazaki J., Smith A.G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 2000, 24:372-376.
21. Nomi M., Atala A., Coppi P.D., Soker S. Principals of neovascularization for tissue engineering. Mol. Aspects Med. 2002, 23:463-483.
22. Nur Fariha M.M., Chua K.H., Tan G.C., Lim Y.H., Hayati A.R. Endogenous and induced angiogenic characteristics of human chorion-derived stem cells. Cell Biol. Int. 2012, 36:1145-1153.
23. Okumura-Nakanishi S., Saito M., Niwa H., Ishikawa F. Oct-3/4 and Sox2 regulate Oct-3/4 gene in embryonic stem cells. J. Biol. Chem. 2005, 280:5307-5317.
24. Pan H.C., Yang D.Y., Chiu Y.T., Lai S.Z., Wang Y.C., Chang M.H., Cheng F.C. Enhanced regeneration in injured sciatic nerve by human amniotic mesenchymal stem cell. J. Clin. Neurosci. 2006, 13:570-575.
25. Park J.E., Chen H.H., Winer J., Houck K.A., Ferrara N. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not Flk-1/KDR. J. Biol. Chem. 1994, 269:25646-25654.
26. Pasquinelli G., Tazzari P., Ricci F., Vaselli C., Buzzi M., Conte R., Orrico C., Foroni L., Stella A., Alviano F., Bagnara G.P., Lucarelli E. Ultrastructural characteristics of human mesenchymal stromal (stem) cells derived from bone marrow and term placenta. Ultrastruct. Pathol. 2007, 31:23-31.
27. Portmann-Lanz C.B., Schoeberlein A., Huber A., Sager R., Malek A., Holzgreve W., Surbek D.V. Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. Am. J. Obstet. Gynecol. 2006, 194:664-673.
28. Rodda D.J., Chew J.L., Lim L.H., Loh Y.H., Wang B., Ng H.H., Robson P. Transcriptional regulation of Nanog by Oct4 and Sox2. J. Biol. Chem. 2005, 280:24731-24737.
29. Sarugaser R., Lickorish D., Baksh D., Hosseini M.M., Davies J.E. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 2005, 23:220-229.
30. Shalaby F., Rossant J., Yamaguchi T.P., Gertsenstein M., Wu X.F., Breitman M.L., Schuh A.C. Failure of blood-island formation and vasculogenesis in flk-1-deficient mice. Nature 1995, 376:62-66.
31. Shi W., Wang H., Pan G., Geng Y., Guo Y., Pei D. Regulation of the pluripotency marker Rex-1 by Nanog and Sox2. J. Biol. Chem. 2006, 281:23319-23325.
32. Suri C., McClain J., Thurston G., McDonald D.M., Zhou H., Oldmixon E.H., Sato T.N., Yancopoulos G.D. Increased vascularization in mice overexpressing Angiopoietin-1. Science 1998, 282:468-471.
33. Tamagawa T., Oi S., Ishiwata I., Ishikawa H., Nakamura Y. Differentiation of mesenchymal cells derived from human amniotic membranes into hepatocyte-like cells in vitro. Hum. Cell 2007, 20:77-84.
34. Tan G.C., Simat S.F., Abdul Rahman H., Tan A.E., Chua K.H. Quantitative RT PCR approach to evaluate the neurogenic and gliagenic gene expression of cultured human amniotic epithelial cells. Med. J. Malaysia 2008, 63:51-52.
35. Teo R., Möhrlen F., Plickert G., Müller W.A., Frank U. An evolutionary conserved role of Wnt signaling in stem cell fate decision. Dev. Biol. 2006, 289:91-99.
36. Tsuji H., Miyoshi S., Ikegami Y., Hida N., Asada H., Togashi I., Suzuki J., Satake M., Nakamizo H., Tanaka M., Mori T., Segawa K., Nishiyama N., Inoue J., Makino H., Miyado K., Ogawa S., Yoshimura Y., Umezawa A. Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes. Circ. Res. 2010, 106:1613-1623.
37. Ventura C., Cantoni S., Bianchi F., Lionetti V., Cavallini C., Scarlata I., Foroni L., Maioli M., Bonsi L., Alviano F., Fossati V., Bagnara G.P., Pasquinelli G., Recchia F.A., Perbellini A. Hyaluronan mixed esters of butyric and retinoic acid drive cardiac and endothelial fate in term placenta human mesenchymal stem cells and enhance cardiac repair in infracted rat hearts. J. Biol. Chem. 2007, 282:14243-14252.
38. Wan Safwani W.K., Makpol S., Sathapan S., Chua K.H. The changes of stemness biomarkers expression in human adipose-derived stem cells during long-term manipulation. Biotechnol. Appl. Biochem. 2011, 58:261-270.
39. Ware C.B., Nelson A.M., Blau C.A. A comparison of NIH-approved human ESC lines. Stem Cells 2006, 24:2677-2684.
40. Wolbank S., Peterbauer A., Fahrner M., Hennerbichler S., van Griensven M., Stadler G., Redl H., Gabriel C. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng. 2007, 13:1173-1183.
41. Wu Y., Chen L., Scott P.G., Tredget E.E. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007, 25:2648-2659.
42. Wulff C., Wilson H., Dickson S.E., Wiegand S.J., Fraser H.M. Hemochorial placentation in the primate: expression of vascular endothelial growth factor, angiopoietins and their receptors throughout pregnancy. Biol. Reprod. 2002, 66:802-812.
43. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000, 407:242-248.
44. Yuan H., Corbi N., Basilico C., Dailey L. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct3. Genes Dev. 1995, 9:2635-2645.
45. Zhao P., Ise H., Hongo M., Ota M., Konishi I., Nikaido T. Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation 2005, 79:528-535.
46. Zhou S., Schuetz J.D., Bunting K.D., Colapietro A.M., Sampath J., Morris J.J., Lagutina I., Grosveld G.C., Osawa M., Nakauchi H., Sorrentino B.P. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side population phenotype. Nat. Med. 2001, 7:1028-1034.